Want to see MLTX full AI Analyst Report?
MoonLake Immunotherapeutics (MLTX) Hedge Fund Trading Activity
677 Followers
No recent Hedge Funds data found for MLTX
Hedge Fund Holdings in MLTX
Based on the 13F filings of 489 Hedge Funds tracked by TipRanks, as submitted to the SEC.
Hedge Fund Confidence Signal
Currently, no data available
Please return soon. This page is being updated.
Hedge Fund Activity
Activity
Star Ranking
| Follow | |||||||
|---|---|---|---|---|---|---|---|
 BlackRock, Inc. | Added | 7.14% | $21,315,581 | <0.01% | |||
 Kenneth Tropin | Graham Capital Management, L.P. | Added | 2.16% | $419,481 | <0.01% |
FAQ
Which hedge funds hold MoonLake Immunotherapeutics?
Currently, no data Available
Are hedge funds buying or selling MLTX?
Currently, no data Available
Where can I see a list of the best rated hedge funds?
You can see a list of the best hedge funds here.
Who is the best-performing hedge fund manager?
The top-rated hedge fund managers can be seen here: Top Hedge Fund Managers
Does Warren Buffet hold shares in MoonLake Immunotherapeutics stock?
Warren Buffet currently does not own shares in MoonLake Immunotherapeutics.
What is a 13F filing, and how does it help investors?
A 13F form, also known as a "Report of Investment Manager," is a quarterly report that investment advisors registered with the Securities and Exchange Commission (SEC) must file if they manage at least $100 million in assets. The 13F form lists all of the publicly traded securities that the investment advisor owns as of the end of the reporting period. To read more about the 13F, click here
